Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Salesforce
CRM
|
+$1.56B |
| 2 |
Broadcom
AVGO
|
+$1.12B |
| 3 |
RTX Corp
RTX
|
+$939M |
| 4 |
CVS Health
CVS
|
+$856M |
| 5 |
Nike
NKE
|
+$776M |
Top Sells
| 1 |
Edwards Lifesciences
EW
|
+$1.62B |
| 2 |
Public Storage
PSA
|
+$1.48B |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 4 |
Qualcomm
QCOM
|
+$824M |
| 5 |
General Motors
GM
|
+$767M |
Sector Composition
| 1 | Technology | 24.22% |
| 2 | Financials | 14.36% |
| 3 | Industrials | 13.12% |
| 4 | Healthcare | 12.96% |
| 5 | Communication Services | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Rexford Industrial Realty
REXR
$10.3B
| $140M | 0.03% |
+2,487,023
| New | +$140M |
|
252
AB InBev
BUD
$114B
| $137M | 0.03% |
2,124,860
+18,280
| +0.9% | +$1.18M |
|
253
Agilon Health
AGL
$443M
| $137M | 0.03% |
10,934,636
+1,521,995
| +16% | +$19.1M |
|
254
Enerpac Tool Group
EPAC
$2.3B
| $135M | 0.03% |
4,347,380
+118,691
| +3% | +$3.69M |
|
|
CTLT
255
DELISTED
CATALENT, INC.
CTLT
| $135M | 0.03% |
2,994,467
+34,856
| +1% | +$1.57M |
|
256
NovoCure
NVCR
$1.36B
| $132M | 0.03% |
8,861,871
-142,621
| -2% | -$2.13M |
|
257
Olin
OLN
$3.02B
| $131M | 0.03% |
2,431,272
-5,212,743
| -68% | -$281M |
|
258
Global Payments
GPN
$20.7B
| $131M | 0.03% |
1,031,108
+13,189
| +1% | +$1.68M |
|
259
Genmab
GMAB
$17.1B
| $130M | 0.03% |
4,057,922
-260,420
| -6% | -$8.32M |
|
260
Moody's
MCO
$91.9B
| $129M | 0.03% |
329,729
+122
| +0% | +$47.6K |
|
261
Evertec
EVTC
$2.14B
| $128M | 0.03% |
3,131,941
+1,209
| +0% | +$49.5K |
|
262
Novanta
NOVT
$4.12B
| $127M | 0.03% |
755,395
-189,439
| -20% | -$31.9M |
|
263
ESCO Technologies
ESE
$5.38B
| $126M | 0.03% |
1,076,662
-80,000
| -7% | -$9.36M |
|
264
Vestis
VSTS
$554M
| $126M | 0.03% |
+5,940,705
| New | +$126M |
|
265
Stellantis
STLA
$26.9B
| $123M | 0.03% |
5,241,826
-1,818,604
| -26% | -$42.6M |
|
266
Accenture
ACN
$149B
| $117M | 0.03% |
+333,287
| New | +$117M |
|
267
BP
BP
$87.3B
| $116M | 0.03% |
3,293,482
+588,029
| +22% | +$20.8M |
|
268
Intuit
INTU
$180B
| $115M | 0.03% |
183,716
+49
| +0% | +$30.6K |
|
269
Alkami Technology
ALKT
$2.63B
| $113M | 0.03% |
4,679,907
+632,061
| +16% | +$15.3M |
|
270
Xenon Pharmaceuticals
XENE
$2.79B
| $113M | 0.03% |
2,455,683
+8,863
| +0.4% | +$408K |
|
271
Essent Group
ESNT
$6.29B
| $111M | 0.02% |
2,108,994
| – | – |
|
272
Floor & Decor
FND
$9.55B
| $110M | 0.02% |
989,703
-23
| -0% | -$2.57K |
|
273
Legend Biotech
LEGN
$6.11B
| $110M | 0.02% |
1,824,687
-8,116
| -0.4% | -$488K |
|
274
Datadog
DDOG
$47.6B
| $109M | 0.02% |
897,186
| – | – |
|
275
Guardant Health
GH
$6.85B
| $108M | 0.02% |
4,001,803
+1,074,452
| +37% | +$29.1M |
|